Download presentation
Presentation is loading. Please wait.
1
Ambulatory Conference: Travel Medicine Hollis Ray, MD June 6, 2011
2
Travel Clinic Should be carried out by persons who have training in the field, particularly for travelers who have complex itineraries or special health needs Primary care physicians and non- specialists should be able to advise travelers who are in good health and visiting low-risk destinations with standard planned activities.
3
Travel Clinic Epidemiology, transmission and prevention of travel-associated infectious diseases A complete understanding of vaccine indications and procedures Prevention and management of non- infectious travel health risks Recognition of major syndromes in returned travelers (e.g., fever, diarrhea, and rash)
4
Immunization Update vaccines/boosters: tetanus, pertussis, diphtheria, Haemophilus influenzae type b, measles, mumps, rubella, varicella, Streptococcus pneumoniae, and influenza Hepatitis A and B, poliomyelitis, and Neisseria meningitidis – –for travel as well as for routine health care. Yellow fever vaccine: endemic zones (Africa and S. America) – –some countries may require as a condition for entry Vaccines against Japanese encephalitis, rabies, tick-borne encephalitis and typhoid fever – –Administered based on a risk assessment – –Quadrivalent meningococcal vaccine is required by Saudi Arabia for religious pilgrims to Mecca for the Hajj or Umrah.
6
Most Common Diagnoses Short Incubation Period (<2 weeks) – –Malaria – –Typhoid fever – –Dengue – –Rickettsial disease – –Hepatitis A Long Incubation Period (>4 weeks) – –Malaria – –Tuberculosis
7
Malaria
8
Malaria Largely preventable Incubation period: 10 days to 1 year Signs and symptoms: GI symptoms, cyclical fevers, anemia, splenomegaly Diagnosis: thick and thin peripheral blood smear – –Thrombocytopenia without leukocytosis CDC Public Health Image Library
9
Infecting Organisms Plasmodium falciparum: potentially fatal and considered an emergency – –Acquired in Africa = 3:1 likelihood – –95% have clinical onset within 2 months exposure – –Peripheral blood smear: parasitemia > 2%, only ring forms, banana-shaped gametocyte, erythrocytes of all sizes infected, erythrocytes contain no Schuffner granules Other species: P. vivax, P. ovale, P. malariae, P. knowlesi – –fevers occurring at regular intervals of 48 to 72 hours
11
Severe Malaria Cerebral malaria, with abnormal behavior, impairment of consciousness, seizures, coma, or other. Severe anemia due to hemolysis Hemoglobinuria Pulmonary edema or ARDS, which may occur even after the parasite counts have decreased in response to treatment Abnormalities in blood coagulation and thrombocytopenia Shock
12
Treatment of Severe Malaria in the United States Artesunate for hospitalized patients with Severe malaria disease High levels of malaria parasites in the blood Inability to take oral medications Lack of timely access to intravenous quinidine Quinidine intolerance or contraindications Quinidine failure
13
Malaria Chemoprophylaxis Largely based on resistance patterns to chloroquine phosphate or hydroxychloroquine sulfate. (IDSA Travel Medicine Guidelines)
17
Typhoid Fever Typically present 1-3 weeks after ingestion of food or water contaminated with Samonella enterica serotype typhi Have visited Indian subcontinent, in the Philippines, or in Latin America Fever and constitutional symptoms – –May have insidious onset – –Abdominal pain, cough, chills – –Diarrhea may eventually develop
18
Typhoid Fever Diagnosis: identify organism in urine, blood, stool, or bone marrow Vaccines partially effective Treatment: 3 rd gen. cephalosporin, floroquinolone, or azithromycin – –Relapse: 2-3 weeks after treatment
19
Typhoid Rash
23
Dengue Fever Primary vector: Aedes mosquito Caused by one of four different serotypes of Flavivirus Incubation period: 4-7 days Fever, severe myalgias, retro-orbital pain Leukopenia and thrombocytopenia Dengue shock syndrome and dengue hemorrhagic fever: second infection with a different serotype
24
Dengue Fever Diffuse erythema or nonspecific maculopapular or petechial rash No specific treatment – –IV fluids Primary preventive approach: mosquito repellent and screens (NEJM 2002)
26
Travelers Diarrhea
27
Travelers Diarrhea Between 20%-50% international travelers – –Onset: usually first week of travel but may occur later Most common agent: enterotoxigenic Escherichia coli (ETEC) Primary source of infection: ingestion of fecally contaminated food or water. Most important risk determinant: traveler's destination – –Latin America, Africa, the Middle East, and Asia – –High-risk: young adults, immunocompromised, pts with inflammatory-bowel disease, diabetes, and persons taking H-2 blockers or antacids.
28
Travelers Diarrhea Prevention: food and liquid hygiene and provision for prompt self-treatment in the event of illness – –Hydration, loperamide (if no fever >38.5 degrees C & no gross blood or mucus in stool) – –Short course (1 dose to 3 days) of a fluoroquinolone, azithromycin or rifaximin Usually resolves in 3-5 days Antibiotic prophylaxis is not recommended for most travelers
30
Prolonged Diarrhea Greater than 2 weeks Less likely to isolate specific organism More likely to be parasitic – –Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, and Cyclospora cayetanensis most frequently identified – –detected in fewer than 1/3 travelers with chronic diarrhea and in only 1-5% travelers with acute diarrhea
32
Hepatitis A Virus Transmitted through fecal contimination of food and drink Treatment: supportive (no antivirals) Vaccination – –Should be immunized at least 2-4 weeks prior to traveling – –Single dose: 100% protection by 4 wks – –2 nd dose administered 6 months later results in antibody titers likely to last many decades
33
Rickettsial Diseases Tick transmitted, occur throughout the world, typically named for geographic region –African tick bite fever (sub- Saharan) –Meditterranean tick bite fever (N. Africa and Middle East) –Exception: RMSF African tick typhus (NEJM 2002)
34
Rickettsial Diseases Headache, fever, myalgias and often a truncal maculopapular or vesicular rash Clinical clue: eschar at site of bite Treatment: doxycycline, self-limited
36
Fungal Infections Coccidioidomycosis: Southwest US, Mexico, and parts of South America Histoplasmosis: Ohio River valley, Mexico, Central America Penicillium marneffei: Southeast Asia, parts of China, Hong Kong, and Taiwan – –Disseminated infection increasing in immunocompromised patients (AIDS)
38
Scabies Due to Sarcoptes scabiei infection Common in – –Developing world – –Adventurous backpackers Sexually active travelers are those most commonly infected
39
(Foot of a person who had recently visited the Caribbean) (NEJM 2002)
40
Cutaneous Larva Migrans Most frequent serpiginous lesion among travelers Results from migration of animal hookworms (e.g., Ancylostoma braziliense and A. caninum) in superficial tissues Usually acquired after direct skin contact with soil or sand contaminated with dog or cat feces Lesions – –may initially be papular or vesicular – –Pruritic – –commonly found on the foot or buttock
42
QUESTIONS
48
The End
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.